Servier

Servier Welcome to our page. Servier is committed to therapeutic progress to serve patient needs.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.

----

To report a suspected adverse event with a Servier drug 👉 https://bit.ly/435zpoI

02/03/2026

💬 Hypertension, heart failure, heart attack... These terms come up often, but do we really know what they mean?​

In this video for by Servier, our health expert Anca explains the main cardiovascular diseases and the warning signs in a simple and informative way.​

📺 A clear, accessible video based on recognized recommendations to help you better understand your heart... and take early action to protect your health.​

If you feel any of this symptom, go visit your doctor for proper guidance.​

​Learn more on servier.com

01/03/2026

💙 AS ONE is an innovative way to support patients with chronic conditions, and reduce nonadherence to medication.

Many chronic diseases such as hypertension, venous disease, dyslipidemia, diabetes, angina pectoris and heart failure share common risk factors. A patient suffering from one of these diseases is more likely to develop another. Managing multiple diseases can be difficult.

💊 AS ONE by Servier brings doctors and patients together through a comprehensive approach to cardiovascular care, diabetes and venous diseases, providing them with the tools they need to get started and stay on the path to better health.

If you have any doubts or symptoms, consult a health care professional.
👉 Watch the video now!

Further information at servier.com

💙💜💚 Today, we stand with the 300 million people worldwide living with a rare disease.Behind each condition, there is a s...
28/02/2026

💙💜💚 Today, we stand with the 300 million people worldwide living with a rare disease.
Behind each condition, there is a story, a family, a fight — and a hope for better diagnosis, care, and treatment.

💜 What is a rare disease?

A condition that affects a small number of people… A disease is considered rare if it affects fewer than 1 in 2,000 people. Together, rare disease patients form a global community that deserves visibility and support. – Rare diseases currently affect 5% if the worldwide population

🧬 Why awareness matters:
Many rare diseases are still misunderstood or underdiagnosed
Patients often face long diagnostic journeys
Research is essential to bring new therapeutic options
Everyone can help by spreading knowledge and compassion

Learn more about Rare Disease Day 👉 https://www.rarediseaseday.org/

Rare Disease Day

28/02/2026

Today is Rare Disease Day 💜

We had the pleasure of speaking with Morgan, the mom behind , mother and full-time caregiver to Madilynn, who lives with spinocerebellar ataxia type 5 — one of the rarest forms of ataxia.

Morgan shared her family’s journey through years of uncertainty, the challenges of raising a child with a rare condition, and the strength they found in honesty, resilience, and joy.

Her message to other families facing a rare diagnosis is a powerful reminder: your feelings are valid and your child remains the same child you love.

💙💜💚 Tomorrow is Rare Disease Day, an opportunity to raise awareness of the impact of rare diseases on patients and their...
27/02/2026

💙💜💚 Tomorrow is Rare Disease Day, an opportunity to raise awareness of the impact of rare diseases on patients and their families 👨👩👧👦

A disease is considered rare if it affects fewer than 1 in 2,000 people. However, this figure may be misleading, as there are more than 300 million people worldwide living with a rare disease 🌍

It's time to make their voices heard and support them in their fight against these little-known, yet debilitating diseases. Join us in raising awareness for Rare Disease Day and showing our solidarity with those affected.

Find out more 👉 https://www.rarediseaseday.org/

Rare Disease Day

💬 “I have to be attentive to the market and market trends, and to analyze the data to make sure our results are in line ...
26/02/2026

💬 “I have to be attentive to the market and market trends, and to analyze the data to make sure our results are in line with the results that are expected by the company.”

💊 Meet Liliana Alvarado, Global Brand Manager Hypertension Health. She works closely with global and local colleagues to ensure every initiative meets the needs of patients and healthcare professionals.

What inspires her? Teamwork, meaningful projects, and the mission to improve lives worldwide. ❤️

26/02/2026

💬 “Our objective is to make sure that customers, patients, and healthcare professionals have access to the right information at the right time via the right channels.”

Meet Joséphine Perret, Omnichannel, Digital & AI Director, and Yann Péoc’h, Head of Digital and Solutions, who are driving Servier’s global digital transformation.

👩‍⚕️👨‍⚕️ Working at the Group’s headquarters in France, they support subsidiaries worldwide to design impactful omnichannel strategies, ensuring that every message reaches the right audience, whether it’s healthcare professionals, pharmacists, or patients.

📲 From developing digital ecosystems to aligning teams and empowering local markets, Joséphine and Yann combine scientific expertise and digital innovation to make health information more accessible and relevant than ever.

25/02/2026

💬 “It’s important to listen to patients so that we can develop medicines and tools that truly meet their needs and not our idea of them.”

🤝 Meet Aude Lemoine André, Global Patient Relations Director, Cardio-Metabolic, whose mission is to ensure that the patient voice is at the heart of every decision.

🔎 A pharmacist by training, Aude found her calling in patient affairs, where she builds bridges between patients, healthcare professionals, and the pharmaceutical industry to co-create meaningful solutions.

From launching Patient Advisory Councils to organizing groundbreaking patient-led events at international congresses, she works to make sure every voice is heard, and that every innovation truly serves those who need it most.

⚖ At Servier, Aude thrives in a collaborative environment that values trust, creativity, and balance.

24/02/2026

The journey of a medicine never truly ends, it evolves every time.

💊 In this final episode, discover how research and innovation continue after approval, refining dosages, exploring new indications, and improving formulations to meet patients’ changing needs.

⚖️ When patents expire, generic medicines ensure wider access while maintaining the same quality and efficacy, balancing innovation and affordability.

🚀 From discovery to lifelong improvement, the life cycle of a medicine is a continuous process driven by science, regulation, and patient needs!

Discover our commitment in R&D at 👉 https://servier.com/en/patients/

23/02/2026

💬 “I really enjoy collaboration. I think it’s amazing to feel that we are all partnering to move towards a common objective, a common goal.”

Meet Ekaterina (Katia) Trunova, formerly Global Forecast and Market Insights Director for Cardio-Metabolic and Venous Diseases at Servier, and now promoted to Business Office Director – Cardio-Metabolism.

📊 With a background in market research and strategic insights, Katia helps teams make data-driven decisions that shape Servier’s long-term strategy, forecasting up to ten years ahead while staying closely connected to teams across the organization.

🤝 What motivates her most is teamwork: the shared sense of purpose, the energy of collaboration, and the opportunity to grow and learn alongside inspiring colleagues every day.

22/02/2026

💬 “Being part of this patient commitment, working in a company that is truly committed to patients, is amazing.”

💊 Meet Liliana Alvarado, who began her career in environmental science before finding her purpose in healthcare and joining Servier in 2013.

❤️👩‍⚕️ As part of the cardiovascular team, she leads marketing and promotional strategy, working hand in hand with global and local colleagues to align every initiative with the needs of patients and healthcare professionals.

What drives her every day? The energy of teamwork, the impact of meaningful projects, and the pride of contributing to Servier’s mission to improve lives around the world.

21/02/2026

❓ Did you know that a medicine doesn't become approved and then it's all done? This is the start of continuous safety monitoring in real-world conditions.

📊 In this episode, we're going to talk about pharmacovigilance. That's the process of tracking a drug's safety, detecting rare side effects, and adapting recommendations as new data emerges. Patients can help by letting us know if they have any unexpected effects.

🩺 Even after launch, Phase 4 clinical trials continue to assess long-term safety and new potential uses. This ensures that patients always receive the safest and most effective care.

🔎 Stay tuned to discover the final stage of the life-cycle of a medicine

Adresse

50, Rue Carnot
Suresnes
92150

Téléphone

+33 1 55 72 60 00

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Servier publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type

Our Story

Servier is an international pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

With a strong international presence in 149 countries and a turnover of € 4.2 billion in 2018, Servier employs 22.000 people worldwide.

Entirely independent, Servier reinvests 25% of its revenue (excluding generic drugs) in research and development and uses all its profits for development.